Back to search results

Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced Solid Tumors

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Yale University - Yale University School of Medicine, New Haven, Connecticut, United States

    Study coordinator · 203-785-6221
    Contact: Principal Investigator (Patricia M LoRusso)

  • Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center, Huntersville, North Carolina, United States

    Study coordinator · 704-947-6599
    Contact: Principal Investigator (John D Powderly)

  • NEXT Houston, Galveston, Texas, United States

    Contact: Principal Investigator (Jennifer M Segar)

  • NEXT Oncology - PARENT, San Antonio, Texas, United States

    Study coordinator · 210-595-5670
    Contact: Principal Investigator (Ildefonso Ismael Rodriguez Rivera)

  • Princess Margaret Cancer Centre, Toronto, Canada

    Study coordinator · Spreafico
    Contact: Principal Investigator (Anna Spreafico)

  • BC Cancer - Vancouver - BC Cancer Agency, Vancouver, Canada

    Study coordinator · 6048776000
    Contact: Principal Investigator (Anna Tinker)

  • National Cancer Center Hospital, Tokyo, Japan

    Study coordinator · +81335422511
    Contact: Principal Investigator (Noboru Yamamoto)

  • Hospital Universitari Vall d'Hebron - VHIO - Oncology - Phase I Unit, Barcelona, Spain

    Contact: Principal Investigator (Elena Garralda Cabanas)

  • NEXT Madrid - Hospital Universitario Quironsalud Madrid, Madrid, Spain

    Study coordinator · +349145219003890100000000
    Contact: Principal Investigator (Valentina Boni)
Study leads

  • Medical Responsible

    Study Director

    EMD Serono Research & Development Institute, Inc.

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)